The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Does retention matter? Treatment duration and improvement in drug use
Abstract
Aim This study examines whether there is a minimum threshold, continuous or non‐linear relationship between the duration of addiction treatment and improvements in drug use. Design Longitudinal cohort study of 62 drug treatment units and 4005 clients in the US National Treatment Improvement Evaluation Study, fielded from 1993 to 1995. Subjects Baseline and 1‐year follow‐up interviews with clients in methadone maintenance, out‐patient non‐methadone, short‐term residential and long‐term residential treatment programs. Measures Improvement in drug use is the difference between the client‐reported peak frequency of drug use (in days per month) in the year prior to the baseline interview minus the peak frequency in the year after discharge. Primary drug, and overall use of the major illicit drugs (heroin, cocaine powder, crack cocaine, and marijuana) are considered separately. Results Controlling for multiple factors, treatment duration had a positive linear relationship with primary drug use improvement among methadone clients and an inverted‐U‐shaped relationship with overall and primary drug use improvements among out‐patient and long‐term residential clients. Improvement with longer duration is greatest for long‐term residential clients. Conclusions Contrary to previous arguments for a sharp retention threshold for onset of treatment effects, we find smooth curves relating treatment duration to drug use improvements in methadone maintenance, out‐patient non‐methadone and long‐term residential modalities. These relationships are effectively linear for durations typically observed in single treatment episodes, but unusually long retention in out‐patient non‐methadone and long‐term residential units appear steadily less predictive of improvement.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“dropout from opioid substitution treatment is associated with relapse and an increased risk of overdose and death (Clausen et al., 2008; Zhang et al., 2003).”
From Feasibility and acceptability of mindful recovery opioid use care continuum (M-ROCC): A concurrent mixed methods study (2021) · cites this paper as Zhang et al., 2003
Citations
Cites
Littell, R. C. (1996) · Medical Entomology and Zoology · Cited by 10,345
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
How we should measure "change": Or should we?
Cronbach, L. J., & Furby, L. (1970) · Psychological Bulletin · doi:10.1037/h0029382 · Cited by 2,456
The Transtheoretical Approach: Crossing Traditional Boundaries of Therapy
Sporakowski, M. J., Prochaska, J. O., & DiClemente, C. C. (1986) · Family Relations · doi:10.2307/584540 · Cited by 1,976
Toward a Comprehensive Model of Change
Prochaska, J. O., & Diclemente, C. C. (1986) · Treating Addictive Behaviors · doi:10.1007/978-1-4613-2191-0_1 · Cited by 1,877
The Effectiveness of Methadone Maintenance Treatment
Ball, J. C., & Ross, A. (1991) · Springer eBooks · doi:10.1007/978-1-4613-9089-3 · Cited by 1,088
Kessler, R. C., Nelson, C. B., McGonagle, K. A., Liu, J., Swartz, M. S., & Blazer, D. G. (1996) · The British Journal of Psychiatry · doi:10.1192/s0007125000298371 · Cited by 1,079
Drug Abuse Treatment: A National Study of Effectiveness
Hubbard, R. L., Marsden, M. E., Rachal, J. V., Harwood, H. J., Cavanaugh, E. R., & Ginzburg, H. M. (1989) · Medical Entomology and Zoology · Cited by 1,028
Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS).
Hubbard, R. L., Craddock, S. G., Flynn, P. M., Anderson, J., & Etheridge, R. M. (1997) · Psychology of Addictive Behaviors · doi:10.1037/0893-164x.11.4.261 · Cited by 603
Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS).
Simpson, D. D., Joe, G. W., & Brown, B. S. (1997) · Psychology of Addictive Behaviors · doi:10.1037/0893-164x.11.4.294 · Cited by 514
Research works printed but not linked: 8
- Borkovec T. D., 1993, Behavioral Treatments for Drug Abuse and Dependence, 249
- Condelli W. S., 1994, Therapeutic Community: Advances in Research and Application, 80
- European Monitoring Centre for Drugs and Drug Addiction (EMCDDA, 2000, Annual Report on the State of the Drugs Problem in the European Union
- General Accounting Office (GAO, 1993, Drug Use Measurement: Strengths, Limitations and Recommendations for Improvement.
- Gerstein D., 1997, National Treatment Improvement Evaluation Survey
- Miller W. R., 1999, Enhancing Motivation for Change in Substance Abuse Treatment.
- National Institute on Drug Abuse, 1999, Principles of Drug Addiction Treatment: a Research‐based Guide
- Tim F. M., 1984, Drug Use Treatment Evaluation: Strategies, Progress, and Prospects
Cited by
Sorted by citations
Strang, J., Volkow, N. D., Degenhardt, L., Hickman, M., Johnson, K., Koob, G. F., Marshall, B. D. L., Tyndall, M., & Walsh, S. L. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0137-5 · Cited by 639
Petry, N. M., Peirce, J. M., Stitzer, M. L., BLAINE, J. D., Roll, J. M., Cohen, A. J., Obert, J. L., Killeen, T. K., Saladin, M. E., Cowell, M., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.10.1148 · Cited by 373
Daughters, S. B., Lejuez, C. W., Bornovalova, M. A., Kahler, C. W., Strong, D. R., & Brown, R. A. (2005) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.114.4.729 · Cited by 336
Medication Treatment of Opioid Use Disorder
Bell, J. R., & Strang, J. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.06.020 · Cited by 331
Stevens, L., Verdejo‐García, A., Goudriaan, A. E., Roeyers, H., Dom, G., & Vanderplasschen, W. (2014) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2014.01.008 · Cited by 340
Treatment of substance abusing patients with comorbid psychiatric disorders
Kelly, T. M., Daley, D. C., & Douaihy, A. B. (2011) · Addictive Behaviors · doi:10.1016/j.addbeh.2011.09.010 · Cited by 306
Marchand, K., Beaumont, S., Westfall, J., Macdonald, S., Harrison, S., Marsh, D. C., Schechter, M. T., & Oviedo‐Joekes, E. (2019) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-019-0227-0 · Cited by 249
Guerrero, E. G., Marsh, J. C., Khachikian, T., Amaro, H. D. L. A., & Vega, W. A. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.07.027 · Cited by 173
GOOD INTENTIONS MEET HARD REALITIES: AN EVALUATION OF THE PROJECT GREENLIGHT REENTRY PROGRAM*
Wilson, J. A., & Davis, R. C. (2006) · Criminology & Public Policy · doi:10.1111/j.1745-9133.2006.00380.x · Cited by 149
The Impact of Benzodiazepine Use on Methadone Maintenance Treatment Outcomes
Brands, B., Blake, J. E., Marsh, D. C., Sproule, B. A., Jeyapalan, R., & Li, S. (2008) · Journal of Addictive Diseases · doi:10.1080/10550880802122620 · Cited by 142
Predictors of Methadone Treatment Retention from a Multi-Site Study: A Survival Analysis
Kelly, S., O'Grady, K., Mitchell, S., Brown, B., & Schwartz, R. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.01.008 · Cited by 136
Substance User Treatment Dropout from Client and Clinician Perspectives: A Pilot Study
Palmer, R. S., Murphy, M. K., Piselli, A., & Ball, S. A. (2009) · Substance Use & Misuse · doi:10.1080/10826080802495237 · Cited by 137
Methadone in pregnancy: treatment retention and neonatal outcomes
Burns, L., Mattick, R. P., Lim, K., & Wallace, C. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01651.x · Cited by 135
Client and program factors associated with dropout from court mandated drug treatment
Evans, E., Li, L., & Hser, Y. (2008) · Evaluation and Program Planning · doi:10.1016/j.evalprogplan.2008.12.003 · Cited by 130
Need-service matching in substance abuse treatment: Racial/ethnic differences
Marsh, J. C., Cao, D., Guerrero, E. G., & Shin, H.-C. (2008) · Evaluation and Program Planning · doi:10.1016/j.evalprogplan.2008.09.003 · Cited by 130
The role of organization and management in substance abuse treatment: Review and roadmap
D’Aunno, T. A. (2006) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2006.06.016 · Cited by 128
Emerging adult age status predicts poor buprenorphine treatment retention
Schuman-Olivier, Z., Weiss, R. D., Hoeppner, B. B., Borodovsky, J., & Albanese, M. J. (2014) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2014.04.006 · Cited by 127
Laudet, A. B., Stanick, V., & Sands, B. (2009) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2009.01.001 · Cited by 125
Integrated substance abuse and child welfare services for women: A progress review
Marsh, J. C., Smith, B. D., & Bruni, M. (2010) · Children and Youth Services Review · doi:10.1016/j.childyouth.2010.06.017 · Cited by 119
Guerrero, E. G., & Andrews, C. M. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.05.020 · Cited by 110
Steinkamp, J., Goldblatt, N. P., Borodovsky, J. T., LaVertu, A. E., Kronish, I. M., Marsch, L. A., & Schuman‐Olivier, Z. (2018) · JMIR Mental Health · doi:10.2196/12493 · Cited by 115
Retention in publicly funded methadone maintenance treatment in two western states
Deck, D. D., & Carlson, M. J. (2005) · The Journal of Behavioral Health Services & Research · doi:10.1007/bf02287327 · Cited by 106
Callaghan, R. C., Hathaway, A., Cunningham, J. A., Vettese, L. C., Wyatt, S., & Taylor, L. (2005) · Addictive Behaviors · doi:10.1016/j.addbeh.2005.07.015 · Cited by 100
Carver, H., Ring, N., Miler, J. A., & Parkes, T. (2020) · Harm Reduction Journal · doi:10.1186/s12954-020-0356-9 · Cited by 114
Groman, S. M., Lee, B., Seu, E., James, A. S., Feiler, K., Mandelkern, M. A., London, E. D., & Jentsch, J. D. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0029-12.2012 · Cited by 94
Brecht, M., Greenwell, L., & Anglin, M. D. (2005) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2005.08.012 · Cited by 93
Teruya, C., Schwartz, R. P., Mitchell, S. G., Hasson, A. L., Thomas, C., Buoncristiani, S. H., Hser, Y., Wiest, K. L., Cohen, A. J., Glick, N., et al. (2014) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2014.921743 · Cited by 91
Patient Satisfaction and Sustained Outcomes of Drug Abuse Treatment
Zhang, Z., Gerstein, D. R., & Friedmann, P. D. (2008) · Journal of Health Psychology · doi:10.1177/1359105307088142 · Cited by 89
Self-citationWhite, W. L., Campbell, M. D., Spencer, R. D., Hoffman, H. A., Crissman, B., & DuPont, R. L. (2014) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2014.901587 · Cited by 84
Pharmacological maintenance treatments of opiate addiction
Bell, J. R. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12051 · Cited by 86
Predictors of Dropout from Psychosocial Treatment in Opioid‐Dependent Outpatients
McHugh, R. K., Murray, H. W., Hearon, B. A., Pratt, E. M., Pollack, M. H., Safren, S. A., & Otto, M. W. (2013) · American Journal on Addictions · doi:10.1111/j.1521-0391.2013.00317.x · Cited by 83
Nosyk, B., Sun, H., Evans, E., Marsh, D. C., Anglin, M. D., Hser, Y., & Anis, A. H. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.03870.x · Cited by 81
The Health Effect of Psychostimulants: A Literature Review
Favrod-Coune, T., & Broers, B. (2010) · Pharmaceuticals · doi:10.3390/ph3072333 · Cited by 84
A Multisite Evaluation of Prison-Based Therapeutic Community Drug Treatment
Welsh, W. N. (2007) · Criminal Justice and Behavior · doi:10.1177/0093854807307036 · Cited by 84
Gender Issues in the Pharmacotherapy of Opioid-Addicted Women: Buprenorphine
Unger, A., Jung, E., Winklbaur, B., & Fischer, G. (2010) · Journal of Addictive Diseases · doi:10.1080/10550881003684814 · Cited by 77
Banta‐Green, C. J., Maynard, C. C., Koepsell, T. D., Wells, E. A., & Donovan, D. M. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02538.x · Cited by 75
Fals-Stewart, W. S., & Lam, W. K. K. (2010) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0018058 · Cited by 74
Friedmann, P. D., Hendrickson, J. C., Gerstein, D. R., & Zhang, Z. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00772.x · Cited by 73
Self-citationStevens, L., Goudriaan, A. E., Verdejo‐García, A., Dom, G., Roeyers, H., & Vanderplasschen, W. (2015) · Psychological Medicine · doi:10.1017/s003329171500001x · Cited by 81
The Continuing Care Model of Substance Use Treatment: What Works, and When Is “Enough,” “Enough?”
Proctor, S. L., & Herschman, P. L. (2014) · Psychiatry Journal · doi:10.1155/2014/692423 · Cited by 70
Marsh, J. C., Angell, B., Andrews, C. M., & Curry, A. (2012) · Journal of the Society for Social Work and Research · doi:10.5243/jsswr.2012.15 · Cited by 70
Guerrero, E. G. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.04.005 · Cited by 72
Harris, A. H. S., Humphreys, K. N., Bowe, T. R., Kivlahan, D. R., & Finney, J. W. (2008) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2008.05.011 · Cited by 70
Building addiction recovery capital through online participation in a recovery community
Bliuc, A., Best, D. W., Iqbal, M., & Upton, K. (2017) · Social Science & Medicine · doi:10.1016/j.socscimed.2017.09.050 · Cited by 68
Impacts of COVID-19 on residential treatment programs for substance use disorder
Pagano, A., Hosakote, S., Kapiteni, K., Straus, E. R., Wong, J., & Guydish, J. R. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2020.108255 · Cited by 67
Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth
Warden, D., Subramaniam, G., Carmody, T. J., WOODY, G. E., Minhajuddin, A., Poole, S. A., Potter, J. S., Fishman, M. J., Bogenschutz, M. P., Patkar, A. A., et al. (2012) · Addictive Behaviors · doi:10.1016/j.addbeh.2012.04.011 · Cited by 67
What is low threshold methadone maintenance treatment?
Strıke, C., Millson, M., Hopkins, S., & Smith, C. (2013) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2013.05.005 · Cited by 66
Kilmer, B., Caulkins, J. P., Midgette, G., Dahlkemper, L., MacCoun, R. J., & Pacula, R. L. (2013) · RAND Corporation eBooks · doi:10.7249/rr466 · Cited by 62
Perron, B. E., & Bright, C. L. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.07.011 · Cited by 61
Spending on substance abuse treatment: how much is enough?
Meara, E. R., & Frank, R. G. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01227.x · Cited by 61
Weinstock, J., Alessi, S. M., & Petry, N. M. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.08.027 · Cited by 60
Yang, F., Lin, P., Li, Y., He, Q., Long, Q., Fu, X., & Luo, Y. (2013) · Harm Reduction Journal · doi:10.1186/1477-7517-10-3 · Cited by 60
Golan, O. K., Andraka‐Christou, B., Totaram, R., Alamo, J., & Nadig, M. (2019) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000584 · Cited by 59
Russolillo, A., Moniruzzaman, A., McCandless, L. C., Patterson, M., & Somers, J. M. (2017) · Addiction · doi:10.1111/add.14059 · Cited by 57
Pasman, E., Kollin, R., Broman, M. J., Lee, G., Agius, E., Lister, J. J., Brown, S., & Resko, S. M. (2022) · Addiction Science & Clinical Practice · doi:10.1186/s13722-022-00316-3 · Cited by 61
Does gender-specific substance abuse treatment for women promote continuity of care?
Claus, R. E., Orwin, R. G., Kissin, W., Krupski, A., Campbell, K. M., & Stark, K. (2006) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2006.06.013 · Cited by 57
Guerrero, E. G., Marsh, J. C., Cao, D., Shin, H.-C., & Andrews, C. M. (2013) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2013.12.008 · Cited by 55
Coerced Treatment for Methamphetamine Abuse: Differential Patient Characteristics and Outcomes
Brecht, M., Anglin, M. D., & Dylan, M. L. (2005) · The American Journal of Drug and Alcohol Abuse · doi:10.1081/ada-200056764 · Cited by 55
Improving Patient Treatment Adherence
Bosworth, H. B. (2010) · Springer eBooks · doi:10.1007/978-1-4419-5866-2 · Cited by 57
Gustafson, D. H., Landucci, G., Mctavish, F. M., Kornfield, R., Johnson, R. A., Mares, M., Westergaard, R. P., Quanbeck, A., Alagöz, E., Pe‐Romashko, K., et al. (2016) · Trials · doi:10.1186/s13063-016-1726-1 · Cited by 54
Salamina, G., Diecidue, R., Vigna‐Taglianti, F., Jarre, P., Schifano, P., Bargagli, A. M., Davoli, M., Amato, L., Perucci, C. A., Faggiano, F., et al. (2010) · Substance Use & Misuse · doi:10.3109/10826081003791932 · Cited by 52
Factors predicting 2-year retention in methadone maintenance treatment for opioid dependence
Strıke, C., Gnam, W., Urbanoski, K. A., Fischer, B., Marsh, D. C., & Millson, M. (2005) · Addictive Behaviors · doi:10.1016/j.addbeh.2004.09.004 · Cited by 49
Stevens, L., Verdejo‐García, A., Roeyers, H., Goudriaan, A. E., & Vanderplasschen, W. (2014) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2014.08.007 · Cited by 49
Wang, Y., Wang, H., Li, W., Zhu, J., Gold, M. S., Zhang, D., Wang, L., Li, Y., Yan, X., Cheng, J., et al. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.08.026 · Cited by 48
Trujols, J., López, I. G., Siñol, N., del Pozo, J., Portella, M. J., & Cobos, J. P. D. L. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.10.014 · Cited by 48
Marchand, K., Oviedo‐Joekes, E., Guh, D. P., Brissette, S., Marsh, D. C., & Schechter, M. T. (2011) · BMC Health Services Research · doi:10.1186/1472-6963-11-174 · Cited by 48
Young adults’ reasons for dropout from residential substance use disorder treatment
Nordheim, K., Walderhaug, E., Alstadius, S., Kern-Godal, A., Arnevik, E. A., & Duckert, F. (2016) · Qualitative Social Work · doi:10.1177/1473325016654559 · Cited by 57
Retention in methadone and buprenorphine treatment among African Americans
Gryczynski, J., Mitchell, S. G., Jaffe, J. H., Kelly, S. M., Myers, C. P., O’Grady, K. E., Olsen, Y. K., & Schwartz, R. P. (2013) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2013.02.008 · Cited by 46
Recovery Management: What If We Really Believed That Addiction Was a Chronic Disorder?
White, W., & Kelly, J. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-960-4_5 · Cited by 58
Antidepressant treatment does not improve buprenorphine retention among opioid-dependent persons
Stein, M. D., Herman, D. S., Kettavong, M., Cioe, P. A., Friedmann, P. D., Tellioğlu, T., & Anderson, B. J. (2010) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2010.05.014 · Cited by 46
Self-citationImpact of Methadone Maintenance Treatment on Women Offenders' Post-Release Recidivism
MacDonald, S. F., MacSwain, M.-A., Cheverie, M., Tiesmaki, M., & Fischer, B. (2014) · European Addiction Research · doi:10.1159/000357942 · Cited by 47
Cournoyer, L., Brochu, S., Landry, M., & Bergeron, J. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.02027.x · Cited by 44
Schuman-Olivier, Z., Borodovsky, J. T., Steinkamp, J., Munir, Q., Butler, K., Greene, M. A., Goldblatt, J., Xie, H. Y., & Marsch, L. A. (2018) · Addiction Science & Clinical Practice · doi:10.1186/s13722-018-0122-4 · Cited by 44
Bukten, A., Skurtveit, S. O., Waal, H., & Clausen, T. (2014) · Addictive Behaviors · doi:10.1016/j.addbeh.2014.05.007 · Cited by 44
Maricich, Y. A., Bickel, W. K., Marsch, L. A., Gatchalian, K. M., Botbyl, J. D., & Luderer, H. F. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1846022 · Cited by 43
Oviedo‐Joekes, E., Nosyk, B., Marsh, D. C., Guh, D. P., Brissette, S., Gartry, C. C., Krausz, M. R., Anis, A. H., & Schechter, M. T. (2009) · Clinical Trials · doi:10.1177/1740774509105222 · Cited by 41
Schuman‐Olivier, Z., Greene, M. C., Bergman, B. G., & Kelly, J. F. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.09.009 · Cited by 42
Treating drug misuse problems : evidence of effectiveness.
Gossop, M. (2006) · Europe PMC (PubMed Central) · Cited by 41
Wild, T. C., Yan Yuan, A., Rush, B. R., & Urbanoski, K. A. (2016) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2016.06.006 · Cited by 51
Redefining Retention: Recovery from the Patient's Perspective
Mitchell, S. G., Morioka, R., Reisinger, H. S., Peterson, J. A., Kelly, S. M., Agar, M., Brown, B. S., O’Grady, K. E., & Schwartz, R. P. (2011) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2011.587392 · Cited by 40
Friedmann, P. D., Katz, E. C., Rhodes, A. G., Taxman, F. S., O’Connell, D. J., Frisman, L. K., Burdon, W. M., Fletcher, B. W., Litt, M. D., Clarke, J. G., et al. (2008) · Journal of Offender Rehabilitation · doi:10.1080/10509670802134184 · Cited by 40
Self-citationScaduto, A. A., & Barbieri, V. (2009) · Ciência & Saúde Coletiva · doi:10.1590/s1413-81232009000200029 · Cited by 39
Relationship Between Medication Adherence and Treatment Outcomes: The COMBINE Study
Zweben, A., Pettinati, H. M., Weiss, R. D., Youngblood, M., Cox, C. E., Mattson, M. E., Gorroochurn, P., & Ciraulo, D. A. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00743.x · Cited by 39
Patient Perspectives Associated with Intended Duration of Buprenorphine Maintenance Therapy
Bentzley, B. S., Barth, K. S., Back, S. E., Aronson, G., & Book, S. W. (2015) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2015.04.002 · Cited by 38
Males and females differ in response to opioid agonist medications.
Jones, H., Fitzgerald, H., & Johnson, R. E. (2005) · American Journal on Addictions · doi:10.1080/10550490590949569 · Cited by 39
Factors Associated with Methadone Treatment Duration: A Cox Regression Analysis
Lin, C.-K., Hung, C., Peng, C.-Y., Chao, E., & Lee, T. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123687 · Cited by 36
Turner, B., & Deane, F. P. (2016) · Therapeutic Communities The International Journal of Therapeutic Communities · doi:10.1108/tc-09-2015-0022 · Cited by 36
Wei, X., Wang, L., Wang, X., Li, J., Li, H., & Jia, W. (2013) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e31829da05b · Cited by 35
Bharat, C., Larney, S., Barbieri, S., Dobbins, T., Jones, N. R., Hickman, M., Gisev, N., Ali, R. L., & Degenhardt, L. J. (2021) · Addiction · doi:10.1111/add.15514 · Cited by 36
Lions, C., Carrieri, P., Michel, L., Mora, M., Marcellin, F., Morel, A., Spire, B., & Roux, P. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.10.018 · Cited by 35
Performance measures for outpatient substance abuse services: Group versus individual counseling
Panas, L., Caspi, Y., Fournier, E., & McCarty, D. W. (2003) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(03)00142-9 · Cited by 35
Supervised Injectable Opioid Treatment for the Management of Opioid Dependence
Bell, J. R., Běláčková, V., & Lintzeris, N. (2018) · Drugs · doi:10.1007/s40265-018-0962-y · Cited by 34
Two-Year Outcomes of Treatment for Methamphetamine Use
Brecht, M., Greenwell, L., von Mayrhauser, C., & Anglin, M. D. (2006) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2006.10400605 · Cited by 34
Treatments for Adolescents With Comorbid ADHD and Substance Use Disorder: A Systematic Review
Zaso, M. J., Park, A., & Antshel, K. M. (2020) · Journal of Attention Disorders · doi:10.1177/1087054715569280 · Cited by 31
Dacosta‐Sánchez, D., González‐Ponce, B. M., Fernández‐Calderón, F., Sánchez‐García, M., & Lozano, O. M. (2022) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1929 · Cited by 32
Oviedo‐Joekes, E., Palis, H., Guh, D. P., Marchand, K., Brissette, S., Harrison, S., Macdonald, S., Lock, K., Anis, A. H., Marsh, D. C., et al. (2019) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.03.012 · Cited by 33
Lee, C. S., Liebschutz, J. M., Anderson, B. J., & Stein, M. D. (2017) · American Journal on Addictions · doi:10.1111/ajad.12533 · Cited by 32
Werb, D., Wagner, K. D., Beletsky, L. A., González‐Zúñiga, P., Rangel, G., & Strathdee, S. A. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.01.011 · Cited by 32
Benefits of concurrent syringe exchange and substance abuse treatment participation
KIDORF, M. S., King, V. L., Pierce, J., Kolodner, K., & Brooner, R. K. (2011) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2010.11.011 · Cited by 32
Substance Misuse and Substance-Related Disorders in Forensic Psychiatry
Gendel, M. H. (2006) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2006.04.010 · Cited by 32
Metadata
- Authors
- Zhang, Z., Friedmann, P. D., & Gerstein, D. R.
- Affiliations
- University of Chicago (US)
- Brown University (US)
- Corresponding author
- Zhang, Zhiwei
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2003-05
- Volume
- 98
- Issue
- 5
- Pages
- 673-684
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W2007620075
- Cited by
- 314
- References
- 41
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 13 · 2023: 11 · 2022: 12 · 2021: 22 · 2020: 13 · 2019: 18 · 2018: 9 · 2017: 13 · 2016: 17 · 2015: 15 · 2014: 18 · 2013: 23 · 2012: 12
- FWCI
- 7.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Addiction (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Substance Abuse and Mental Health Services Administration
- National Institute on Drug Abuse (R01DA013615, R01-DA13615)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- treatment duration, treatment retention, addiction treatment, methadone maintenance treatment, outpatient care, residential treatment, heroin use, cocaine use, cannabis use, treatment effects
- MeSH terms
- Adolescent, Adult, Aged, Ambulatory Care, Analysis of Variance, Female, Humans, Longitudinal Studies, Male, Methadone, Middle Aged, Narcotics, Patient Compliance, Residential Treatment, Time Factors, Treatment Outcome, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review